Mohadese Dashtkoohi

Dr. Mohadese Dashtkoohi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
AJArash Jalali
Arash Jalali
AHAli Hassanzadeh
Ali Hassanzadeh
MNMohammad Sadeq Najafi
Mohammad Sadeq Najafi
SNSepehr Nayebirad
Sepehr Nayebirad
MDMohadese Dashtkoohi
Mohadese Dashtkoohi
ASAkbar Shafiee
Akbar Shafiee
Aim: We systematically reviewed and meta-analyzed the predictors of major adverse cardiac and cerebrovascular events (MACE/MACCE) in older adults who underwent PCI. Methods: Three databases, PubMed, Embase, and Scopus, were searched for observational studies considering the out-of-hospital MACE/MACCE in adults ≥ 60 years old with coronary artery disease (acute or chronic) who underwent PCI. Studies were eligible if they had determined at least two statistically significant predictors of MACE/MACCE by multivariable analysis. We used the QUIPS tool to evaluate the risk of bias in the studies. Random-effects meta-analysis was utilized to pool the hazard ratios (HRs) of the most reported predictors. Results: A total of 34 studies were included in the review. Older age (HR = 1.04, 95% Confidence Interval (CI): 1.03–1.06, P-value < 0.001), diabetes (HR = 1.36, 95% CI: 1.22–1.53, P < 0.001), history of myocardial infarction (MI) (HR = 1.88, 95% CI: 1.37–2.57, P < 0.001), ST-elevation MI (STEMI) at presentation (HR = 1.72, 95% CI: 1.37–2.18, P < 0.001), reduced left ventricular ejection fraction (LVEF) (HR = 2.01, 95% CI: 1.52–2.65, P < 0.001), successful PCI (HR = 0.35, 95% CI: 0.27–0.47, P < 0.001), eGFR (HR = 0.99, 95% CI: 0.97-1.00; P-value = 0.04) and left main coronary artery (LMCA) disease (HR = 2.07, 95% CI: 1.52–2.84, P < 0.001) were identified as predictors of MACE. Conclusion: We identified older age, diabetes, history of MI, STEMI presentation, lower LVEF, and LMCA disease increased the risk of MACE/MACCE after PCI in older adults. Meanwhile, higher eGFR and successful PCI predicted lower adverse events risk. Future studies should focus on a more robust methodology and a precise definition of MACE. Registration: PROSPERO (CRD42023480332).

27 April 2024 in IJC Heart & Vasculature
Verified
Journal Article
Open access
MNMohammad Sadeq Najafi
Mohammad Sadeq Najafi
SNSoroush Nematollahi
Soroush Nematollahi
AVAhmad Vakili-Basir
Ahmad Vakili-Basir
AJArash Jalali
Arash Jalali
AGArezoo Gholami
Arezoo Gholami
STSeyed Hossein Ahmadi Tafti
Seyed Hossein Ahmadi Tafti
Reduced left ventricular ejection fraction (LVEF) is a well-known predictor of adverse events after cardiac surgery. We aimed to assess the outcomes in patients with low LVEF undergoing coronary artery bypass graft. In this retrospective cohort, we included all patients with left ventricular ejection fraction ≤ 40 who underwent coronary artery bypass grafting between March 2007 and March 2016 (with a median follow-up of nine years) at Tehran Heart Center. Demographics and clinical characteristics were extracted from the data registry. Akaike information criterion (AIC) was used. The univariate Cox regression was performed. We investigated the predictors of mortality and major adverse cardiac and cerebrovascular events (MACCE) using Cox multivariable regression. In total, 5,532 cases (79 % male) with a mean age of 65.58 were included in the study. The nine-year overall survival was calculated at 68 %, and more than half of the patients had MACCE (55 %). In adjusted multivariable Cox regression analysis, moderate to severe mitral valve regurgitation, glomerular filtration rate ≤ 60, mild right ventricular dysfunction, and valvular heart disease independently predicted higher mortality. The abovementioned predictors and peripheral vascular disease significantly increased MACCE. Our study indicates the clinical significance of mitral regurgitation, valvular heart disease, and renal function in patients with low ejection fraction treated by coronary artery bypass grafting surgery. Identifying predictors of adverse events can help with clinical decision-making and risk stratification, ultimately improving patient outcomes.

2 April 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
PDParham Dastjerdi
Parham Dastjerdi
MMMehrdad Mahalleh
Mehrdad Mahalleh
HSHedieh Shayesteh
Hedieh Shayesteh
MNMohammad Sadeq Najafi
Mohammad Sadeq Najafi
RNRoozbeh Narimani-Javid
Roozbeh Narimani-Javid
MTMasih Tajdini
Masih Tajdini
Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of heart failure cases, with increasing prevalence due to aging and risk factors such as hypertension and obesity. Liver dysfunction is common in HFpEF and may impact prognosis. This systematic review and meta-analysis aimed to evaluate the prognostic value of liver function markers (albumin, bilirubin, AST, ALT, ALP) in HFpEF patients. A systematic search of PubMed, Embase, Web of Science, and Scopus was conducted for studies assessing the association of liver markers with adverse outcomes in HFpEF. The primary outcome was a composite of heart failure-related hospitalization or death. Hazard ratios (HR) were pooled using a random-effects model, and heterogeneity was assessed using the I² statistic. Twenty studies involving 30,623 patients were included. Serum albumin, the main marker of our study, was significantly associated with a reduced risk of adverse outcomes in a meta-analysis of 16 studies (HR 0.71, 95% CI: 0.61–0.83; I² = 87%). After excluding outliers, heterogeneity decreased (I² = 23%), and the association remained significant (HR 0.75, 95% CI: 0.69–0.82). Although no significant associations were found for AST, ALT, ALP, or bilirubin with adverse outcomes, the limited number of studies for these markers may have contributed to the lack of statistical significance. Higher serum albumin levels predict better outcomes in HFpEF, while other liver function markers showed limited prognostic utility. Serum albumin may serve as a valuable marker for risk stratification in HFpEF.

4 July 2023 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
REReza Ershadi
Reza Ershadi
SRShahab Rafieian
Shahab Rafieian
MSMohammadreza Salehi
Mohammadreza Salehi
HKHossein Kazemizadeh
Hossein Kazemizadeh
HAHesam Amini
Hesam Amini
MVMatin Vahedi
Matin Vahedi
Introduction: COVID-19 Patients may be at risk for involving with spontaneous pneumothorax. However, clinical data are lacking in this regard. In this study, we aimed to investigate the demographic, clinical, and radiological characteristics and survival predictors in COVID-19 patients with pneumothorax. Methods: This is a retrospectivestudy conducted on COVID-19 patients with pneumothorax that had been hospitalized at hospital. l from December 2021 to March 2022. The chest computed tomography (CT) scan of all patients was reviewed by an experienced pulmonologist in search of pulmonary pneumothorax. Survival analysis was conducted to identify the predictors of survival in patients with COVID-19 and pneumothorax. Results: A total of 67 patients with COVID-19 and pneumothorax were identified. Of these, 40.7% were located in the left lung, 40.7% were in the right lung, and 18.6% were found bilaterally. The most common symptoms in the patient with pneumothorax were dyspnea (65.7%), increased cough severity (53.7%), chest pain (25.4%), and hemoptysis (16.4%). The frequency of pulmonary left and right bullae, pleural effusion, andfungus ball were 22.4%, 22.4%, 22.4%, and 7.5%, respectively. Pneumothorax was managed with chest drain (80.6%), chest drain and surgery (6%), and conservatively (13.4%). The 50-day mortality rate was 52.2% (35 patients). The average survival time for deceased patients was 10.06 (2.17) days. Conclusions: Our results demonstrated that those with pleural effusion or pulmonary bullae have a lower survival rate. Further studies are required to investigate the incidence and causality relation between COVID-19 and pneumothorax.

25 March 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMohammad Haddadi
Mohammad Haddadi
LSLeyla Sahebi
Leyla Sahebi
FHFatemeh Hedayati
Fatemeh Hedayati
ISIqbal H. Shah
Iqbal H. Shah
MPMohammadamin Parsaei
Mohammadamin Parsaei
SHSedigheh Hantoushzadeh
Sedigheh Hantoushzadeh
Background: The topic of induced abortion has been a subject of extensive debate among various moral and religious frameworks and continues to pose significant challenges within the domains of medical ethics and policy formulation. In the context of Iran, an Islamic republic, the approach to induced abortion has been notably influenced by historical, social, and political dynamics. Following the implementation of the ‘Rejuvenation of the Population and Protection of the Family Law (RPPF)’ in 2021, access to induced abortion and contraceptive measures has been markedly restricted as a response to concerns surrounding population decline. Objective: This study aims to assess the attitudes of Iranian medical and health science students toward induced abortion as future executives of health programs. Methods: This cross-sectional study administered a structured questionnaire for self-completion to medical and health science students of Tehran University of Medical Sciences, including medical students, obstetrics and gynecology residents, and nursing and midwifery students. The scoring of responses was between ‒12 and + 12, with the score ranging from 0 to positive, 12 showing an attitude negative to induced abortion, and the score below zero to ‒12 reflecting a positive attitude toward induced abortion. Results: A total of 237 participants were involved in the study, with 52% being female, and 60% originally from cities other than Tehran. The median (min, max) of the total score of the attitude toward induced abortion was ‒5.0 (12,10). The mean score varied by the age of the respondents, with ‒4.0 (‒12, 10) for those aged above 30 years compared to ‒5.0 (‒12,10) for those aged below 30 years (P-value = 0.043). The score was 0.0 (‒12,10) for married compared to ‒6.0 (‒12,10) among single participants (P-value < 0.001). The score for participants who agreed with RPPF was 0.0 (‒12,10), compared to a more positive attitude of ‒8.0 (‒12,9) for participants who disagreed (P-value < 0.001). Conclusion: Iranian medical and health science students support induced abortion before 16 weeks of gestation. The attitudes of medical students who are future providers of health care and implementers of RPPF and other health laws are, therefore, at variance with current laws and policies.

24 July 2025 in Acta Haematologica
Verified
Journal Article
Closed access
MNMohammadamin Noorafrooz
Mohammadamin Noorafrooz
RGRobert Peter Gale
Robert Peter Gale
MDMohadese Dashtkoohi
Mohadese Dashtkoohi
Background: Chimeric antigen receptor (CAR)-natural killer (NK)/T-cells offer a new approach in immune therapy of haematological cancers. NK/T-cells bridge innate and adaptive immunity with strong anti-cancer effects. Unlike allogeneic CAR-T-cells, CAR-NK/T-cells do not require TCR genetic deletion to prevent major MHC recognition, have a lower risk of graft-versus-host disease, and can be used universally. Summary: Pre-clinical studies report CAR-NK/T-cells effectively target antigens such as CD19 and B-cell maturation antigen in B-cell lymphomas and plasma cell myeloma. Compared with CAR-T-cells, CAR-NK/T-cells have faster immune responses, more cytotoxicity and better safety. Recent innovations increase efficacy of CAR-NK/T-cell therapies. Early clinical trials report promising safety and efficacy. Although still in the early phases of development, advances in NK/T-cell therapy are overcoming prior challenges. Key Messages: CAR-NK/T-cells may prove a safer, more flexible form of cell therapy of haematological cancers.